Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the united states

Digestive Diseases and Sciences

Volumn 54, Issue 9, 2009, Pages 2031-2039

  Wong, Robert J ^a   Corley, Douglas A ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

Cancer epidemiology; Primary liver cancer; Racial disparities; Survival differences

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ETHNICITY; FEMALE; GROUPS BY AGE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; RADIOFREQUENCY ABLATION; SEX DIFFERENCE; TREATMENT RESPONSE; UNITED STATES; AGE; ETHNOLOGY; LIVER TUMOR; MORTALITY; NATIONAL HEALTH ORGANIZATION; RACE; SURVIVAL; TIME;

AGE FACTORS; CARCINOMA, HEPATOCELLULAR; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; NATIONAL CANCER INSTITUTE (U.S.); SEER PROGRAM; SEX FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; UNITED STATES;

EID: 68249146520     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0661-8     Document Type: Article

References (50)

1. DM Parkin F Bray J Ferlay 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108
2. M Varela J Bruix 2006 Hepatocellular carcinoma in the United States: Lessons from a population-based study in Medicare recipients J Hepatol 44 1 8 10 10.1016/j.jhep.2005.11.001 (Pubitemid 41772507)
3. F Bosch J Ribes M Diaz 2004 Primary liver cancer: worldwide incidence and trends Gastroenterology 127 Supp1 5 S5 S16 10.1053/j.gastro.2004.09.011 (Pubitemid 39423365)
4. K Kiyosawa T Umemura T Ichijo 2004 Hepatocellular carcinoma: recent trends in Japan Gastroenterology 127 supp 1 5 S17 S26 10.1053/j.gastro.2004.09. 012 (Pubitemid 39423366)
5. C Verhoef O Visser RA de Man 2004 Hepatocellular carcinoma in the Netherlands incidence, treatment, and survival patterns Eur J Cancer 40 10 1530 1538 10.1016/j.ejca.2004.03.013 (Pubitemid 38757741)
6. J West H Wood RF Logan 2006 Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001 Br J Cancer 94 11 1751 1758 10.1038/sj.bjc.6603127 (Pubitemid 43924943)
7. HB El-Serag KL Rudolph 2007 Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 7 2557 2576 10.1053/j.gastro.2007. 04.061 (Pubitemid 46890874)
8. HB El-Serag AC Mason C Key 2001 Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States Hepatology 33 1 62 66 10.1053/jhep.2001.21041 (Pubitemid 32016888)
9. WG Cance AK Stweart HR Menck 2000 The national cancer database report on treatment patterns for hepatocellular carcinomas Cancer 88 4 912 920
10. HB El-Serag AB Siegel JA Davila 2006 Treatment and outcomes of treating of hepatocellular carcinoma among medicare recipients in the United States: a population-based study J Hepatol 44 1 158 166 10.1016/j.jhep.2005.10.002 (Pubitemid 41772530)
11. JH Liu PW Chen SM Asch 2004 Surgery for hepatocellular carcinoma: does it improve survival? Ann Surg Oncol 11 3 298 303 10.1245/ASO.2004.03.042 (Pubitemid 40486770)
12. JA Davila HB El-Serag 2006 Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study Clin Gastroenterol Hepatol 4 1 104 110 10.1016/S1542-3565(05)00745-7 (Pubitemid 43129531)
13. D Sloane H Chen C Howell 2006 Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival J Natl Med Assoc 98 12 1934 1939
14. HB El-Serag JA Davila NJ Petersen 2003 The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update Ann Intern Med 139 10 817 823
15. KA Mcglynn RE Tarone HB El-Serag 2006 A comparison of the trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States Can Epid Bio Prev 15 6 1198 1203 10.1158/1055-9965.EPI-05-0811
16. PL Chin DZ Chu KG Clarke 1999 Ethnic differences in the behavior of hepatocellular carcinoma Cancer 85 9 1931 1936
17. AM Di Bisceglie AC Lyra M Schwartz 2003 Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status Am J Gastroenterol 98 9 2060 2063
18. R Wong DA Corley 2008 Racial and ethnic variations in hepatocellular carcinoma incidence within the United States Am J Med 121 6 525 531 10.1016/j.amjmed.2008.03.005 (Pubitemid 351694349)
19. S Nair J Eustace PJ Thuluvath 2002 Effect of race on outcome of orthotopic liver transplantation: a cohort study Lancet 359 9303 287 293 10.1016/S0140-6736(02)07494-9 (Pubitemid 34119291)
20. LE Harrison T Reichman B Koneru 2004 Racial discrepancies in the outcome of patients with hepatocellular carcinoma Arch Surg 139 9 992 996 10.1001/archsurg.139.9.992 (Pubitemid 39186751)
21. S Pignata C Gallo B Daniele 2006 Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly: a study of the Cancer of the Liver Italian Program (CLIP) Crit Rev Oncol Hematol 59 3 243 249 10.1016/j.critrevonc.2006.01.002 (Pubitemid 44294863)
22. MF Yuen HJ Yuan DK Wong 2005 Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications Gut 54 11 1610 1614 10.1136/gut.2005.065136 (Pubitemid 41531781)
23. EK Teo SH Han N Terrault 2001 Liver transplantation in patients with hepatitis b virus infection: outcome in Asian versus white patients Hepatology 34 1 126 132 10.1053/jhep.2001.25271 (Pubitemid 32591492)
24. WR Kim JJ Poterucha WK Kremers 2004 Outcome of liver transplantation for hepatitis B in the United States Liver Transpl 10 8 968 974 10.1002/lt.20217 (Pubitemid 39232749)
25. AN Ananthakrishnan K Saeian 2008 Racial differences in liver transplantation outcomes in the MELD era Am J Gastroenterol 103 4 901 910 10.1111/j.1572-0241.2008.01809.x
26. AB Siegel RB [tmp] McBride HB El-Serag 2008 Racial disparities in the utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002 Am J Gastroenterol 103 1 120 128
27. Ries LAG, Melbert D, Krapcho M, eds. SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute; 2007.
28. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat database: incidence - SEER 13 regs limited-use, Nov 2006 sub (1992-2004) - linked to county attributes - total U.S., 1969-2004 counties, National Cancer Institute, DCCPS Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission. ( http://www.seer.cancer.gov ).
29. World Health Organization. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
30. Young JL, Roffers SD, Ries LAG, eds. EER Summary Staging Manual - 2000 Codes and Coding Instructions. Bethesda, MD: National Cancer Institute NIH Pub. No. 01-4969; 2001.
31. K Fiscella P Franks MR Gold 2000 Inequality in quality: addressing socioeconomic, racial, and ethnic disparitieis in health care JAMA 283 19 2579 2584 10.1001/jama.283.19.2579
32. Brown ER, HJKF Foundation. Racial and Ethnic Disparities in Access to Health Insurance and Health care. Los Angeles: UCLA Center for Health Policy Research; 2000.
33. EC Schneider LL Leape JS Weissman 2001 Racial differences in cardiac revascularization rates: does "overuse" explain higher rates among white patients? Ann Intern Med 135 5 328 337
34. AM Epstein JS Weissman EC Schneider 2003 Race and gender disparities in rates of cardiac revascularization: do they reflect appropriate use of procedures or problems in quality of care? Med Care 41 11 1240 1255 10.1097/01.MLR.0000093423.38746.8C
35. JZ Ayanian IS Udvarhelyi CA Gatsonis 1993 Racial differences in the use of revascularization procedures after coronary angiography JAMA 269 20 2642 2646 10.1001/jama.269.20.2642 (Pubitemid 23147700)
36. P Franks K Fiscella 2008 Reducing disparities downstream: prospects and challenges J Gen Intern Med 23 672 677 10.1007/s11606-008-0509-0
37. K Fiscella P Franks MR Gold CM Clancy 2000 Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care JAMA 283 2579 2584 10.1001/jama.283.19.2579
38. CJ Chen MW Yu YF Liaw 1997 Epidemiological characteristics and risk factors of hepatocellular carcinoma J Gastroenterol Hepatol 12 9-10 S294 S308 10.1111/j.1440-1746.1997.tb00513.x
39. RP Beasley LY Hwang CC Lin 1981 Hepatocellular carcinoma and hepatitis B virus a prospective study of 22 707 men in Taiwan Lancet 2 8256 1129 1133 10.1016/S0140-6736(81)90585-7
40. F Donato P Boffetta M Puoti 1998 (1998) A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infection in causing hepatocellular carcinoma Int J Cancer 75 3 347 354
41. JP Villeneuve M Desrochers C Infante-Rivard 1994 A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal Gastroenterology 106 4 1000 1005
42. BJ [tmp] McMahon SR Alberts RB Wainwright 1990 Hepatitis B-related sequelae: prospective study of 1400 hepatitis B surface antigen-positive Alaskan native carriers Arch Intern Med 150 5 1051 1054 10.1001/archinte.150.5.1051 (Pubitemid 20155330)
43. M Sherman KM Peltekian C Lee 1995 Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population Hepatology 22 2 432 438
44. MJ Alter D Kruszon-Moran OV Nainan 1999 The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 341 8 556 562 10.1056/NEJM199908193410802 (Pubitemid 29384163)
45. GL Armstrong EP Simard GM [tmp] McQuillan 2006 The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 Ann Intern Med 144 10 705 714
46. VK Rustgi 2007 The epidemiology of hepatitis C infection in the United States J Gastroenterol 42 7 513 521 10.1007/s00535-007-2064-6 (Pubitemid 47190067)
47. IU Park AL Taylor 2007 Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review Ann Fam Med 5 5 444 452 10.1370/afm.708 (Pubitemid 47535976)
48. The ALLHAT Officers Coordinators for the ALLHAT Collaborative Research Group 2002 Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attach trial (ALLHAT) JAMA 288 23 2981 2997 10.1001/jama.288.23.2981 (Pubitemid 35471160)
49. J Mchutchinson T Poynard S Pianko 2000 The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C Gastroenterology 119 5 1317 1323 10.1053/gast.2000.19289
50. J Fleckenstein 2004 Chronic hepatitis C in African Americans and other minority groups Curr Gastroenterol Rep 6 1 66 70 10.1007/s11894-004-0028-z